Literature DB >> 5062123

Elevated serum-creatine phosphokinase activity in a family with malignant hyperpyrexia.

E K Zsigmond, W H Starkweather, G S Duboff, K Flynn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5062123

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  8 in total

1.  Lability of human creatine kinase isoenzymes at 37 degrees C: a complication of electrophoretic separation.

Authors:  D A Nealon; A R Henderson
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

2.  Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

Authors:  B A Britt; L Endrenyi; P L Peters; F H Kwong; L Kadijevic
Journal:  Can Anaesth Soc J       Date:  1976-05

3.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

4.  Rigidity, hyperpyrexia and coma following fluphenazine enanthate.

Authors:  H Y Meltzer
Journal:  Psychopharmacologia       Date:  1973

5.  The caffeine test of isolated human muscle in relation to malignant hyperthermia.

Authors:  W Kalow; B A Britt; A Richter
Journal:  Can Anaesth Soc J       Date:  1977-11

6.  Serum creatine phosphokinase (CPK) isoenzymes in perinatal asphyxia.

Authors:  M M Thangavel; P L Chordia; N Rudolph
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

7.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11

8.  Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).

Authors:  E H Flewellen; T E Nelson; D E Bee
Journal:  Can Anaesth Soc J       Date:  1980-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.